AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment Conference
09 Septiembre 2020 - 7:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that
Scott Myers, Chief Executive Officer, and Brian Piekos, Chief
Financial Officer, will participate in a fireside chat at the H.C.
Wainwright 22nd Annual Global Investment Conference on Tuesday,
September 15, 2020 at 10:30 a.m. Eastern Time.
A live audio webcast of the virtual event will be accessible
through the Investors section of the company’s website
at www.amagpharma.com. A replay of the webcast will be
archived on the company’s website for 30 days.
About AMAG
AMAG is a commercial stage biopharmaceutical company focused on
bringing innovative products to patients with unmet medical needs.
The company does this by leveraging its development and commercial
expertise to invest in and grow its pharmaceutical products across
a range of therapeutic areas. For additional company information,
please visit www.amagpharma.com.
AMAG Pharmaceuticals®, the logo and designs, are registered
trademarks of AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contact: Loraine
Spreen617-866-0303
AMAG Pharmaceuticals (NASDAQ:AMAG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about AMAG Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias